搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
biopharma-reporter
11 分钟
FDA places hold on Novavax’s COVID-influenza combo vaccine
A report of a case of motor neuropathy in a patient who received the vaccine last year has led the FDA to halt its ...
biopharma-reporter
7 小时
Wave claims first clinical RNA editing title in rare genetic disease
Wave Life Sciences reports that it has successfully carried out RNA editing in two patients with alpha-1 antitrypsin ...
biopharma-reporter
7 小时
Investors and big pharma no longer avoiding techbio companies
Investors and big pharma companies are waking up to the potential of techbio companies after years of avoidance, say experts ...
biopharma-reporter
2 天
FDA approves Pfizer's antibody treatment for hemophilia
The approval of Hympavzi makes it the first treatment for both hemophilia A and B to be administered through a pre-filled pen ...
biopharma-reporter
2 天
MilliporeSigma opens new €290m U.S. biosafety testing facility
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has recently opened its new ...
biopharma-reporter
3 天
Women in STEM: Gitte Barknowitz’s journey to leading global initiatives
From exploring the wonders of plants as a curious teen to leading global initiatives at SCIEX, Gitte Barknowitz has carved ...
biopharma-reporter
6 天
Jane Koo on leading regulatory affairs at CTMC: A journey from mAbs to cellular therapies
Jane Koo, head of regulatory affairs at CTMC, plays an important role in accelerating the development and commercialization ...
biopharma-reporter
7 天
Astellas licenses AviadoBio’s dementia gene therapy candidate
The Japanese big pharma adds the new gene therapy candidate to its pipeline in a US$50 million deal in equity and upfront ...
biopharma-reporter
9 天
Automation in cell therapy manufacturing and CAR-T therapy: Cytiva puts the spotlight on ...
As cell therapies continue to advance, the need for better automated, large-scale manufacturing options increases.
biopharma-reporter
14 天
Resolution Therapeutics scores £63.5 million Series B
The UK cell therapy biotech will now advance its first candidate cell therapy to clinical trials for treatment of liver ...
biopharma-reporter
7 天
Evaxion’s AI-immunology platform shines in multiple clinical trials
Evaxion’s proprietary AI-Immunology platform has shown in clinical trials that it can select clinically relevant cancer ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈